Score Breakdown
Offering Ability
80
Cash Runway
40
Float Risk
35
Warrant Exposure
50
Convertible Debt
40
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 24%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.61 approaching $1 threshold
📜 Warrant Exercise
model 25%
• Significant warrants: 20% of shares outstanding
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (66/100)
Market Data
Market Cap$22.12M
Shares Outstanding15.37M
Float11.73M
Cash$20.56M
DebtN/A
Short InterestN/A
Institutional Holdings
10 institutional holders · 3.32M shares
#1
Adage Capital Partners GP L.L.C.
730.0K shares
#2
Squadron Capital Management LLC
713.5K shares
#3
Ikarian Capital, LLC
678.1K shares
+ 7 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest627.2K
Days to Cover5.5
% of Float5.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2024-12-31
S-3
SHELF
2026-05-08
4
INSIDER TRANSACTION
2026-04-28
8-K
8K EVENT
2026-04-15
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual TRAW Dilution Snapshot
Traws Pharma, Inc. (TRAW) has a DilutionScore of 66/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 3.1M.
- Recent SEC activity tracked for TRAW: S-3 on 2026-05-08; 4 on 2026-04-28; 8-K on 2026-04-15.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: